February 14, 2020
In an SEC filing, Wave Life Sciences announced it will cut its staff by nearly a quarter after a difficult few months. At the end […]
February 21, 2020
Drug pricing remains a hot topic, and a new report from GoodRx ranking the country’s 20 costliest drugs shows that the most expensive drugs sold at […]
February 25, 2020
By Jordan Warshafsky, Partner, Ashton Tweed See this article on LinkedIn. When developing their corporate brand, pharmaceutical and biotech executives often stress their company culture, mission, […]
March 6, 2020
BALANCING RESPONSIBILITIES TO SUPPORT NEW LEADERS Dr. Francois Nader knows all about time management. When we last talked to him in 2016, he was the Board […]
March 6, 2020
Healthcare executives are keeping their eyes on Amazon, but when KLAS Research asked over 300 healthcare leaders to identify the most potentially disruptive company in healthcare, […]
March 6, 2020
Warren Buffett has bet big on Biogen. Buffet’s Berkshire Hathaway bought 648,447 shares of Biogen at a combined worth of $192.4M near the end of 2019, […]
March 6, 2020
Amid an industrywide price-fixing probe that has caught some of the largest generics players, another former executive faces federal charges––this time from Novartis’ generics unit. […]
March 6, 2020
Frank Reynolds, the founder of Medford biotech PixarBio who claimed his company had developed a painkiller that would replace morphine, was sentenced to seven years in […]
March 6, 2020
Thermo Fisher Scientific plans to acquire Qiagen in a deal valued at $11.5B, putting an end to doubts first voiced last November. The deal is expected […]